ArticleInternational journal of fertility & sterility2026
A Compound Heterozygous Missense Variant in The
Article in International journal of fertility & sterility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infertility affects approximately 50 million couples worldwide, with both men and women being equally affected. Male infertility is a complex issue with genetic factors playing a significant role. Conditions such as Klinefelter syndrome (XXY), Y chromosome microdeletions (YCMDs), and monogenic mutations can contribute to male infertility. Currently, hereditary factors account for 4% of male infertility cases, while the causes of 60-70% of cases remain unknown. Ongoing research aims to identify new genes and variants related to male fertility to improve diagnostic methods. More than 2000 genes are believed to be involved in preserving germ cells and ensuring normal meiosis, with more than 100 genes already identified for male infertility. Materials and Methods: In this case series study, we assessed a patient with unexplained male infertility, who also had a brother with a similar issue. We used whole exome sequencing (WES) technology, segregation analysis and analyzed the data through bioinformatics tools. Results: Bioinformatics analysis and Sanger sequencing revealed that two infertile brothers had a compound heterozygous (CH) mutation with missense variants in dynein axonemal heavy chain 5 (DNAH5) gene: one variant in exon 9, (c.1121T>C: p.Ile374Thr), and another in exon 66, (c.11437C>T: p.Arg3813Trp). The protein structure analysis showed that the Ile374Thr variant is located near the outer dynein arm-docking subunit 1 (ODA-D1) and ODA-D3. Additionally, the Arg3813Trp variant replaces the positively charged arginine with a hydrophobic tryptophan residue, which may lead to local instability in the protein structure, particularly in the ATP-binding site. Conclusion: Our study reports a CH presence of a missense variant in DNAH5 within a family experiencing male infertility. In silico structural predictions suggest a potential role of these DNAH5 variants in causing fertility issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.